Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

556
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
556
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional nanozyme therapy accelerates hematoma clearance and attenuates genome damage and senescence after intracerebral hemorrhage.

bioRxiv : the preprint server for biology·2026
Same author

A new <sup>68</sup>Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancer.

EJNMMI radiopharmacy and chemistry·2026
Same author

Sex differences in cluster headache: insights from the Chinese Cluster Headache Register Individual Study (CHRIS).

The journal of headache and pain·2026
Same author

Corrigendum to "Anthropogenic and climate impacts on carbon stocks of grassland ecosystems in Inner Mongolia and adjacent region" [Sci. Total Environ. 946 (2024) 174054].

The Science of the total environment·2025
Same author

The lysine degradation pathway analyzed with <sup>1</sup>H-NMR-targeted metabolomics of MG63 cells on poly(l-lactide)-based scaffolds.

RSC advances·2025
Same author

Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study.

The journal of headache and pain·2025

Related Experiment Video

Updated: Apr 7, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.9K

Quantifying and Reducing Uncertainties in Cancer Therapy.

Harrison H Barrett1, David S Alberts2, James M Woolfenden3

  • 1College of Optical Sciences, University of Arizona, Tucson AZ 85721 ; Center for Gamma-Ray Imaging, Department of Medical Imaging, University of Arizona, Tucson AZ 85724 ; University of Arizona Cancer Center, Tucson AZ 85724.

Proceedings of Spie--The International Society for Optical Engineering
|July 14, 2015
PubMed
Summary

This study explores using mathematical models and imaging to estimate therapeutic efficacy in chemotherapy. It introduces the area under the therapy operating characteristic curve (AUTOC) for personalized cancer treatment optimization.

Keywords:
PETPrecision medicineSPECTTherapy Operating Characteristicchemotherapynormal tissue complicationspersonalized medicineradiation therapytumor control

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 7, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.9K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Area of Science:

  • Medical Physics
  • Oncology
  • Radiopharmacology

Background:

  • Chemotherapy and radiation therapy face uncertainties in drug/dose delivery, efficacy, and normal tissue toxicity.
  • The therapy operating characteristic (TOC) curve visualizes tumor control versus normal tissue complication probabilities.
  • Area under the TOC (AUTOC) serves as a metric for therapeutic efficacy, similar to AUROC for diagnostic efficacy.

Purpose of the Study:

  • To adapt the AUTOC metric for chemotherapy using mathematical models and imaging data.
  • To enable personalized therapy assessment and optimization for individual cancer patients.
  • To investigate the role of Emission Computed Tomography (PET/SPECT) in estimating AUTOC for chemotherapy.

Main Methods:

  • Utilizing mathematical models for drug delivery and tumor response.
  • Integrating patient-specific imaging data (e.g., PET, SPECT) with radiobiological models.
  • Calculating the area under the therapy operating characteristic curve (AUTOC) for individual patients.

Main Results:

  • Demonstrated the potential of using mathematical models and imaging to estimate patient-specific AUTOC for chemotherapy.
  • Established a framework for rigorous assessment and optimization of chemotherapy regimens.
  • Highlighted the importance of imaging radiolabeled chemotherapy drugs for personalized therapy.

Conclusions:

  • Mathematical modeling combined with imaging offers a pathway to personalized chemotherapy.
  • AUTOC estimation can guide the optimization of therapeutic regimens for individual patients.
  • PET/SPECT imaging of radiolabeled drugs is crucial for this personalized approach to cancer therapy.